Prediction Model for Familial Aggregated HBV‐Associated Hepatocellular Carcinoma Based on Serum Biomarkers
ABSTRACT Background Accurate assessment of the risk of familial aggregated hepatitis B virus (HBV)‐associated hepatocellular carcinoma (HCC) and regular surveillance for these patients at high risk may be valuable to reduce the occurrence and improve the prognosis of HCC. Aim This study aimed to dev...
Saved in:
| Main Authors: | Linmei Zhong, Guole Nie, Qiaoping Wu, Honglong Zhang, Haiping Wang, Jun Yan |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2025-06-01
|
| Series: | Cancer Reports |
| Subjects: | |
| Online Access: | https://doi.org/10.1002/cnr2.70253 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Evaluation of serum ESPL1 as a biomarker for early diagnosis of HBV-related hepatocellular carcinoma
by: Lu-Huai Feng, et al.
Published: (2025-04-01) -
HBV sequence integrated to enhancer acting as oncogenic driver epigenetically promotes hepatocellular carcinoma development
by: Lu Chen, et al.
Published: (2025-05-01) -
Integrating bulk and single cell sequencing data to identify prognostic biomarkers and drug candidates in HBV associated hepatocellular carcinoma
by: Yanjie Zhong, et al.
Published: (2025-07-01) -
The role of immune regulation in HBV infection and hepatocellular carcinogenesis
by: Hailong Zheng, et al.
Published: (2025-03-01) -
Postoperative hepatitis B virus reactivation and its impact on survival in HBV-related hepatocellular carcinoma patients undergoing conversion therapy with interventional therapy combined with tyrosine kinase inhibitors and immune checkpoint inhibitors
by: Shaowei Xu, et al.
Published: (2025-07-01)